Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
46
A Quote, Financials, Valuation and Earnings
Last price:
$138.33
Seasonality move
:
5.24%
Day range:
$137.77 - $138.57
52-week range:
$96.43 - $160.27
Dividend yield:
0.72%
P/E ratio:
30.27x
P/S ratio:
5.68x
P/B ratio:
5.82x
Volume:
509K
Avg. volume:
2.2M
1-year change:
1.63%
Market cap:
$39.2B
Revenue:
$6.9B
EPS (TTM):
$4.57
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
A
Agilent Technologies, Inc.
|
$1.8B | $1.58 | 7.63% | 23.83% | $168.29 |
|
AVTR
Avantor, Inc.
|
$1.6B | $0.23 | -2.99% | -70.55% | $13.32 |
|
AZTA
Azenta, Inc.
|
$156.4M | $0.20 | -0.42% | 86.12% | $40.17 |
|
BRKR
Bruker Corp.
|
$847M | $0.32 | -2.17% | 619.12% | $51.79 |
|
HBIO
Harvard Bioscience, Inc.
|
$20M | $0.01 | -5.93% | 8650% | $2.00 |
|
RVTY
Revvity, Inc.
|
$699.6M | $1.14 | 4.17% | 98.36% | $114.38 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
A
Agilent Technologies, Inc.
|
$138.32 | $168.29 | $39.2B | 30.27x | $0.25 | 0.72% | 5.68x |
|
AVTR
Avantor, Inc.
|
$11.28 | $13.32 | $7.7B | 10.97x | $0.00 | 0% | 1.17x |
|
AZTA
Azenta, Inc.
|
$34.51 | $40.17 | $1.6B | -- | $0.00 | 0% | 2.66x |
|
BRKR
Bruker Corp.
|
$48.12 | $51.79 | $7.3B | 77.08x | $0.05 | 0.42% | 2.12x |
|
HBIO
Harvard Bioscience, Inc.
|
$0.73 | $2.00 | $32.3M | -- | $0.00 | 0% | 0.37x |
|
RVTY
Revvity, Inc.
|
$96.78 | $114.38 | $11B | 48.40x | $0.07 | 0.29% | 4.09x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
A
Agilent Technologies, Inc.
|
34.45% | 1.666 | 8.55% | 1.40x |
|
AVTR
Avantor, Inc.
|
40.92% | 0.979 | 45.33% | 0.90x |
|
AZTA
Azenta, Inc.
|
3.35% | 2.112 | 4.55% | 2.22x |
|
BRKR
Bruker Corp.
|
45.23% | 0.852 | 40.19% | 0.76x |
|
HBIO
Harvard Bioscience, Inc.
|
75.26% | 4.098 | 218.87% | 0.35x |
|
RVTY
Revvity, Inc.
|
31.35% | 0.948 | 33.71% | 1.32x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies, Inc.
|
$977M | $443M | 13.42% | 20.9% | 23.8% | $452M |
|
AVTR
Avantor, Inc.
|
$526.5M | $138.4M | -0.81% | -1.4% | 8.52% | $171.7M |
|
AZTA
Azenta, Inc.
|
$72.3M | $2.9M | 1.39% | 1.44% | 1.85% | -$5.7M |
|
BRKR
Bruker Corp.
|
$399.6M | $55.2M | -0.56% | -1.2% | 6.42% | -$54.1M |
|
HBIO
Harvard Bioscience, Inc.
|
$11.2M | $245K | -68.29% | -155.33% | 1.19% | $482K |
|
RVTY
Revvity, Inc.
|
$325.9M | $90.9M | 2.12% | 3.05% | 13% | $120M |
Agilent Technologies, Inc. vs. Competitors
-
Which has Higher Returns A or AVTR?
Avantor, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of -43.84%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Avantor, Inc.'s return on equity of -1.4%.
Company Gross Margin Earnings Per Share Invested Capital AAgilent Technologies, Inc.52.5% $1.53 $10.3B AVTRAvantor, Inc.32.42% -$1.04 $9.4B -
What do Analysts Say About A or AVTR?
Agilent Technologies, Inc. has a consensus price target of $168.29, signalling upside risk potential of 21.67%. On the other hand Avantor, Inc. has an analysts' consensus of $13.32 which suggests that it could grow by 18.1%. Given that Agilent Technologies, Inc. has higher upside potential than Avantor, Inc., analysts believe Agilent Technologies, Inc. is more attractive than Avantor, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AAgilent Technologies, Inc.9 8 0 AVTRAvantor, Inc.4 13 1 -
Is A or AVTR More Risky?
Agilent Technologies, Inc. has a beta of 1.273, which suggesting that the stock is 27.284% more volatile than S&P 500. In comparison Avantor, Inc. has a beta of 0.930, suggesting its less volatile than the S&P 500 by 7.02%.
-
Which is a Better Dividend Stock A or AVTR?
Agilent Technologies, Inc. has a quarterly dividend of $0.25 per share corresponding to a yield of 0.72%. Avantor, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Avantor, Inc. pays out -- of its earnings as a dividend. Agilent Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios A or AVTR?
Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Avantor, Inc. quarterly revenues of $1.6B. Agilent Technologies, Inc.'s net income of $434M is higher than Avantor, Inc.'s net income of -$711.8M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 30.27x while Avantor, Inc.'s PE ratio is 10.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.68x versus 1.17x for Avantor, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AAgilent Technologies, Inc.5.68x 30.27x $1.9B $434M AVTRAvantor, Inc.1.17x 10.97x $1.6B -$711.8M
-
Which has Higher Returns A or AZTA?
Azenta, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of 32.45%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Azenta, Inc.'s return on equity of 1.44%.
Company Gross Margin Earnings Per Share Invested Capital AAgilent Technologies, Inc.52.5% $1.53 $10.3B AZTAAzenta, Inc.45.4% $1.11 $1.8B -
What do Analysts Say About A or AZTA?
Agilent Technologies, Inc. has a consensus price target of $168.29, signalling upside risk potential of 21.67%. On the other hand Azenta, Inc. has an analysts' consensus of $40.17 which suggests that it could grow by 16.39%. Given that Agilent Technologies, Inc. has higher upside potential than Azenta, Inc., analysts believe Agilent Technologies, Inc. is more attractive than Azenta, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AAgilent Technologies, Inc.9 8 0 AZTAAzenta, Inc.1 4 0 -
Is A or AZTA More Risky?
Agilent Technologies, Inc. has a beta of 1.273, which suggesting that the stock is 27.284% more volatile than S&P 500. In comparison Azenta, Inc. has a beta of 1.288, suggesting its more volatile than the S&P 500 by 28.831%.
-
Which is a Better Dividend Stock A or AZTA?
Agilent Technologies, Inc. has a quarterly dividend of $0.25 per share corresponding to a yield of 0.72%. Azenta, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Azenta, Inc. pays out -- of its earnings as a dividend. Agilent Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios A or AZTA?
Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Azenta, Inc. quarterly revenues of $159.2M. Agilent Technologies, Inc.'s net income of $434M is higher than Azenta, Inc.'s net income of $51.7M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 30.27x while Azenta, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.68x versus 2.66x for Azenta, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AAgilent Technologies, Inc.5.68x 30.27x $1.9B $434M AZTAAzenta, Inc.2.66x -- $159.2M $51.7M
-
Which has Higher Returns A or BRKR?
Bruker Corp. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of -6.8%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Bruker Corp.'s return on equity of -1.2%.
Company Gross Margin Earnings Per Share Invested Capital AAgilent Technologies, Inc.52.5% $1.53 $10.3B BRKRBruker Corp.46.44% -$0.41 $4.5B -
What do Analysts Say About A or BRKR?
Agilent Technologies, Inc. has a consensus price target of $168.29, signalling upside risk potential of 21.67%. On the other hand Bruker Corp. has an analysts' consensus of $51.79 which suggests that it could grow by 7.62%. Given that Agilent Technologies, Inc. has higher upside potential than Bruker Corp., analysts believe Agilent Technologies, Inc. is more attractive than Bruker Corp..
Company Buy Ratings Hold Ratings Sell Ratings AAgilent Technologies, Inc.9 8 0 BRKRBruker Corp.7 5 1 -
Is A or BRKR More Risky?
Agilent Technologies, Inc. has a beta of 1.273, which suggesting that the stock is 27.284% more volatile than S&P 500. In comparison Bruker Corp. has a beta of 1.174, suggesting its more volatile than the S&P 500 by 17.405%.
-
Which is a Better Dividend Stock A or BRKR?
Agilent Technologies, Inc. has a quarterly dividend of $0.25 per share corresponding to a yield of 0.72%. Bruker Corp. offers a yield of 0.42% to investors and pays a quarterly dividend of $0.05 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Bruker Corp. pays out 26.44% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios A or BRKR?
Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Bruker Corp. quarterly revenues of $860.5M. Agilent Technologies, Inc.'s net income of $434M is higher than Bruker Corp.'s net income of -$58.5M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 30.27x while Bruker Corp.'s PE ratio is 77.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.68x versus 2.12x for Bruker Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AAgilent Technologies, Inc.5.68x 30.27x $1.9B $434M BRKRBruker Corp.2.12x 77.08x $860.5M -$58.5M
-
Which has Higher Returns A or HBIO?
Harvard Bioscience, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of -5.98%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Harvard Bioscience, Inc.'s return on equity of -155.33%.
Company Gross Margin Earnings Per Share Invested Capital AAgilent Technologies, Inc.52.5% $1.53 $10.3B HBIOHarvard Bioscience, Inc.54.23% -$0.03 $56.9M -
What do Analysts Say About A or HBIO?
Agilent Technologies, Inc. has a consensus price target of $168.29, signalling upside risk potential of 21.67%. On the other hand Harvard Bioscience, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 175.71%. Given that Harvard Bioscience, Inc. has higher upside potential than Agilent Technologies, Inc., analysts believe Harvard Bioscience, Inc. is more attractive than Agilent Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AAgilent Technologies, Inc.9 8 0 HBIOHarvard Bioscience, Inc.1 1 0 -
Is A or HBIO More Risky?
Agilent Technologies, Inc. has a beta of 1.273, which suggesting that the stock is 27.284% more volatile than S&P 500. In comparison Harvard Bioscience, Inc. has a beta of 1.531, suggesting its more volatile than the S&P 500 by 53.123%.
-
Which is a Better Dividend Stock A or HBIO?
Agilent Technologies, Inc. has a quarterly dividend of $0.25 per share corresponding to a yield of 0.72%. Harvard Bioscience, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Harvard Bioscience, Inc. pays out -- of its earnings as a dividend. Agilent Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios A or HBIO?
Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Harvard Bioscience, Inc. quarterly revenues of $20.6M. Agilent Technologies, Inc.'s net income of $434M is higher than Harvard Bioscience, Inc.'s net income of -$1.2M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 30.27x while Harvard Bioscience, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.68x versus 0.37x for Harvard Bioscience, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AAgilent Technologies, Inc.5.68x 30.27x $1.9B $434M HBIOHarvard Bioscience, Inc.0.37x -- $20.6M -$1.2M
-
Which has Higher Returns A or RVTY?
Revvity, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of 6.76%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Revvity, Inc.'s return on equity of 3.05%.
Company Gross Margin Earnings Per Share Invested Capital AAgilent Technologies, Inc.52.5% $1.53 $10.3B RVTYRevvity, Inc.46.63% $0.41 $10.7B -
What do Analysts Say About A or RVTY?
Agilent Technologies, Inc. has a consensus price target of $168.29, signalling upside risk potential of 21.67%. On the other hand Revvity, Inc. has an analysts' consensus of $114.38 which suggests that it could grow by 18.18%. Given that Agilent Technologies, Inc. has higher upside potential than Revvity, Inc., analysts believe Agilent Technologies, Inc. is more attractive than Revvity, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AAgilent Technologies, Inc.9 8 0 RVTYRevvity, Inc.8 8 0 -
Is A or RVTY More Risky?
Agilent Technologies, Inc. has a beta of 1.273, which suggesting that the stock is 27.284% more volatile than S&P 500. In comparison Revvity, Inc. has a beta of 1.059, suggesting its more volatile than the S&P 500 by 5.937%.
-
Which is a Better Dividend Stock A or RVTY?
Agilent Technologies, Inc. has a quarterly dividend of $0.25 per share corresponding to a yield of 0.72%. Revvity, Inc. offers a yield of 0.29% to investors and pays a quarterly dividend of $0.07 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Revvity, Inc. pays out 11.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios A or RVTY?
Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Revvity, Inc. quarterly revenues of $698.9M. Agilent Technologies, Inc.'s net income of $434M is higher than Revvity, Inc.'s net income of $47.2M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 30.27x while Revvity, Inc.'s PE ratio is 48.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.68x versus 4.09x for Revvity, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AAgilent Technologies, Inc.5.68x 30.27x $1.9B $434M RVTYRevvity, Inc.4.09x 48.40x $698.9M $47.2M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
